{"result": "(\"entity\"<|>RUMINATION SYNDROME<|>EVENT<|>Rumination Syndrome is a gastrointestinal disorder characterized by the repeated regurgitation of food, which can lead to nutritional deficiencies and other health issues.)\n##\n(\"entity\"<|>CEDERHOLM T<|>PERSON<|>Cederholm T is an author of a consensus report on malnutrition criteria in clinical nutrition.)\n##\n(\"entity\"<|>FERNÁNDEZ AP<|>PERSON<|>Fernández AP is an author of a study on yeyunostomies in digestive surgery.)\n##\n(\"entity\"<|>HALLAND M<|>PERSON<|>Halland M is an author who contributed to the diagnosis and treatment of Rumination Syndrome.)\n##\n(\"entity\"<|>KESSSING BF<|>PERSON<|>Kessing BF is an author who researched objective manometric criteria for the Rumination Syndrome.)\n##\n(\"entity\"<|>TACK J<|>PERSON<|>Tack J is an author who has published works on functional gastroduodenal disorders.)\n##\n(\"entity\"<|>STANGHELLINI V<|>PERSON<|>Stanghellini V is an author who has contributed to the understanding of gastroduodenal disorders.)\n##\n(\"entity\"<|>LOPEZ-COLOMBO A<|>PERSON<|>López-Colombo A is an author who studied the epidemiology of functional gastrointestinal disorders in Mexico.)\n##\n(\"entity\"<|>ABSAH I<|>PERSON<|>Absah I is an author who has researched the pathophysiology, diagnosis, and treatment of Rumination Syndrome.)\n##\n(\"entity\"<|>BLONDEAU K<|>PERSON<|>Blondeau K is an author who studied the effects of Baclofen on symptoms of Rumination Syndrome.)\n##\n(\"entity\"<|>PAUWELS A<|>PERSON<|>Pauwels A is an author who conducted a randomized controlled study on Baclofen for Rumination Syndrome.)\n##\n(\"entity\"<|>HEJAZI RA<|>PERSON<|>Hejazi RA is an author who reviewed current concepts and treatments for Rumination Syndrome.)\n##\n(\"entity\"<|>SANZ-PARIS A<|>PERSON<|>Sanz-Paris A is an author who provided evidence on the management of Rumination Syndrome.)\n##\n(\"relationship\"<|>CEDERHOLM T<|>RUMINATION SYNDROME<|>Cederholm T authored a report on malnutrition criteria relevant to the management of Rumination Syndrome<|>5)\n##\n(\"relationship\"<|>FERNÁNDEZ AP<|>RUMINATION SYNDROME<|>Fernández AP's study on yeyunostomies may relate to nutritional management in patients with Rumination Syndrome<|>4)\n##\n(\"relationship\"<|>HALLAND M<|>RUMINATION SYNDROME<|>Halland M's work on diagnosis and treatment is directly related to understanding and managing Rumination Syndrome<|>8)\n##\n(\"relationship\"<|>KESSSING BF<|>RUMINATION SYNDROME<|>Kessing BF's research on manometric criteria aids in the diagnosis of Rumination Syndrome<|>7)\n##\n(\"relationship\"<|>TACK J<|>RUMINATION SYNDROME<|>Tack J's publications on functional disorders provide insights into the management of Rumination Syndrome<|>6)\n##\n(\"relationship\"<|>STANGHELLINI V<|>RUMINATION SYNDROME<|>Stanghellini V's research on gastroduodenal disorders is relevant to understanding Rumination Syndrome<|>5)\n##\n(\"relationship\"<|>LOPEZ-COLOMBO A<|>RUMINATION SYNDROME<|>López-Colombo A's epidemiological study may provide context for the prevalence of Rumination Syndrome<|>3)\n##\n(\"relationship\"<|>ABSAH I<|>RUMINATION SYNDROME<|>Absah I's research on pathophysiology and treatment is crucial for managing Rumination Syndrome<|>9)\n##\n(\"relationship\"<|>BLONDEAU K<|>RUMINATION SYNDROME<|>Blondeau K's study on Baclofen directly addresses treatment options for Rumination Syndrome<|>8)\n##\n(\"relationship\"<|>PAUWELS A<|>RUMINATION SYNDROME<|>Pauwels A's randomized study on Baclofen contributes to treatment strategies for Rumination Syndrome<|>8)\n##\n(\"relationship\"<|>HEJAZI RA<|>RUMINATION SYNDROME<|>Hejazi RA's review of concepts and treatments is essential for understanding Rumination Syndrome<|>7)\n##\n(\"relationship\"<|>SANZ-PARIS A<|>RUMINATION SYNDROME<|>Sanz-Paris A's evidence on management strategies is relevant to the treatment of Rumination Syndrome<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: nivel central10,11 .\n              Se conoce poco acerca de la evolución a largo plazo del trastorno. En niños\n     suele remitir espontáneamente, pero en adultos puede persistir durante meses, y el\n     cumplimiento continuado del tratamiento durante varias semanas es fundamental para\n     reducir la frecuencia de los episodios de regurgitación o incluso su resolución12 .\n              De momento no hay bibliografía donde se detalle cómo debe ser el manejo\n     nutricional en esta patología. Un estudio menciona que se produce una pérdida de peso\n     en un 42% de estos pacientes y que en ocasiones es necesario el empleo de nutrición\n\n\n\n170\n---\nenteral o parenteral 13 pero no aporta más detalles acerca de la vía y forma de abordaje\nnutricional.\n\n\n\n         En personas con DM y nutrición enteral domiciliaria, se recomienda la utiliza-\nción de fórmulas especificas de diabetes frente a las estándar, dado que facilitan un\nmejor control metabólico14 .\nConclusiones\n         El síndrome de rumiación es un trastorno poco conocido y probablemente\ninfradiagnosticado. Su abordaje nutricional precoz resulta fundamental para prevenir\nla desnutrición asociada a un aporte calórico insuficiente. En personas con DM que\nademás presentan esta patología, el control glucémico óptimo se convierte en un reto\naún mayor.\n\n\n\n                                                                                          171\n---\n     Bibliografía\n     1.  Cederholm T, Jensen GL, Correia MITD, González MC, Fukushima R, Higashiguchi T, et al. GLIM\n     criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition\n     community. Clin Nutr. 2019;38(1):1-9.\n\n\n\n     2. Fernández AP, Vitcopp GM. Yeyunostomías. Cirugía Digestiva. 2009; 243(2):1-7.\n\n\n\n     3. Halland M, Pandolfino J, Barba E. Diagnosis and Treatment of Rumination Syndrome. Clin Gastroen-\n     terol Hepatol. 2018;16(10):1549-55.\n\n\n\n     4. Kessing BF, Bredenoord AJ, Smout AJPM. Objective Manometric Criteria for the Rumination Syndrome:\n     Am J Gastroenterol. 2014;109(1):52-9.\n\n\n\n     5. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada J-R, et al. Functional Gastroduodenal\n     Disorders. Gastroenterology. 2006;130(5):1466-79.\n\n\n\n     6. Stanghellini V, Chan FKL, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. Gastroduodenal Disorders.\n     Gastroenterology. 2016;150(6):1380-92.\n\n\n\n     7.  Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI\n     disorders: a population-based study. Am J Gastroenterol. 2002;97(9):2290-9.\n\n\n\n     8. López-Colombo A, Morgan D, Bravo-González D, Montiel-Jarquín A, Méndez-Martínez S, Schmulson\n     M. The Epidemiology of Functional Gastrointestinal Disorders in Mexico: A Population-Based Study.\n     Gastroenterol Res Pract. 2012;2012:1-8.\n\n\n\n     9. Absah I, Rishi A, Talley NJ, Katzka D, Halland M. Rumination syndrome: pathophysiology, diagnosis,\n     and treatment. Neurogastroenterol Motil. 2017;29(4):e12954.\n\n\n\n     10. Blondeau K, Boecxstaens V, Rommel N, Farré R, Depeyper S, Holvoet L, et al. Baclofen Improves\n     Symptoms and Reduces Postprandial Flow Events in Patients With Rumination and Supragastric\n     Belching. Clin Gastroenterol Hepatol. 2012;10(4):379-84.\n\n\n\n     11. Pauwels A, Broers C, Van Houtte B, Rommel N, Vanuytsel T, Tack J. A Randomized Double-Blind,\n     Placebo-Controlled, Cross-Over Study Using Baclofen in the Treatment of Rumination Syndrome. Am\n     J Gastroenterol. 2018;113(1):97-104.\n\n\n\n     12. Hejazi RA, McCallum RW. Rumination Syndrome: A Review of Current Concepts and Treatments.\n     Am J Med Sci. 2014;348(4):324-9.\n\n\n\n     13.  O’Brien MD, Bruce BK, Camilleri M. The rumination syndrome: clinical features rather than\n     manometric diagnosis. Gastroenterology. 1995;108(4):1024-9.\n\n\n\n     14.  Sanz-Paris A, Álvarez-Hernández J, Ballesteros-Pomar MD, Botella-Romero F, León-Sanz M,\n     Martín-Palmero Á, et al. Evidence\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}